fbpx

PainChek Ltd

PCK.AX

$0.02

Closing

0.00

1D

▼-25.65%

YTD

PCK

BBG002N7WGP6

Exchange

Sector

Market cap

$32.24M

Volume

260,399

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$32.24M

Analysts' Rating

-

Price Target (Mean)

0.00

Total Analysts

0

P/E

Operating Margin

-366.13%

Beta

0.97

Revenue Growth

16.12%

52 week high

$0.03

52 week low

$0.02

Div. Yield

%

EPS Growth

0.00

Company Profile

PainChek Ltd is an Australia-based company, which develops pain assessment technologies. The Company’s principal activities are development and commercialization of mobile medical device applications that provide pain assessment for individuals that are unable to communicate with their carers. The Company’s PainChek Universal is a complete point-of-care solution that combines the existing PainChek Application with the numerical rating scale (NRS). PainChek Application uses artificial intelligence and facial recognition to detect pain in those who cannot self-report. This gives a voice to those who cannot verbalize pain, whilst also driving objectivity and consistency in all assessments. For those who can self-report, PainChek Universal also includes access to the NRS, a standard used to document pain levels amongst these individuals. PainChek Universal also supports pain assessment using both tools at the point of care, for those people whose ability to communicate fluctuates.